Why the study?
Does the log(TG)/HDL-C ratio correlate with cardiometabolic risk and beta-cell function loss in males with type 2 diabetes?
Does the log(TG)/HDL-C ratio correlate with cardiometabolic risk and beta-cell function loss in males with type 2 diabetes?
The log(TG)/HDL-C ratio is a simple and useful marker to estimate atherogenic dyslipidemia, residual cardiovascular risk, and beta-cell function loss in men with type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
May flag residual cardiometabolic risk in T2D men; hypothesis-generating and requires prospective validation before clinical use.
Hermans et al. (2010) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: